Pfizer logged a 0.5% change during today's evening session, and is now trading at a price of $33.47 per share. On average, analysts give it a target price of $44.24.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The large-cap company is based in the United States. Pfizer currently returns an annual dividend yield of 4.9%.
Make Sure to Consider the Following Before Buying Pfizer:
-
Pfizer has moved -21.0% over the last year.
-
PFE has a forward P/E ratio of 10.2 based on its EPS guidance of 3.29.
-
Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 2.0%.
-
The company has a price to earnings growth (PEG) ratio of -0.69.
-
Its Price to Book (P/B) ratio is 1.91
Pfizer Has Irregular Cash Flows
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-23 | 29,267,000 | -3,236,000 | 32,503,000 | -7.9 |
| 2022-02-24 | 32,580,000 | -2,711,000 | 35,291,000 | 112.2 |
| 2021-02-25 | 14,405,000 | -2,226,000 | 16,631,000 | 13.65 |
| 2020-02-27 | 12,588,000 | -2,046,000 | 14,634,000 | -18.53 |
| 2019-02-28 | 15,826,000 | -2,136,000 | 17,962,000 | -3.87 |
| 2018-02-22 | 16,468,000 | -2,217,000 | 18,685,000 |
Pfizer's free cash flows have a decent average of $22.62 Billion over the last 6 years, but they are highly variable since their coefficient of variability is 55816610558.6%. The compounded average growth rate over this period is 0.0%.
